Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

PUFA intake linked to reduced risk of heart failure, kidney disease and preterm delivery

Omega-3 polyunsaturated fats (PUFAs) found in seafood may reduce arterial stiffness and improve heart function in chronic heart failure, according to new research. These fats, better known as EPA and DHA, may also help in the immediate aftermath of a stroke.

11 Aug 2011

Red meat consumption may increase risk of type 2 diabetes

A new study by Harvard School of Public Health (HSPH) researchers finds a strong association between the consumption of red meat-particularly when the meat is processed-and an increased risk of type 2 diabetes.

11 Aug 2011

PCOS Challenge television series win national award for 'Best Informational Feature'

PCOS Challenge television series addressing Polycystic Ovarian Syndrome win national award for "Best Informational Feature." PCOS Challenge was named the professional category winner for programming from over 3,000 education, government and public stations across the country by the Alliance for Community Media.

10 Aug 2011

First renal denervation with Medtronic Symplicity Catheter System performed in Latin America

Medtronic today announced the first use in Latin America of renal denervation with the Medtronic Symplicity Catheter System™ to treat a patient with resistant hypertension, which is defined as high blood pressure despite treatment with three or more anti-hypertensive medications. Hypertension is an especially dangerous disease affecting hundreds of millions of people worldwide.

From Medtronic 10 Aug 2011

Simcere second quarter total revenue increases 0.3% to US$84.4 million

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended June 30, 2011.

9 Aug 2011

UCSD opens first cardiovascular center in the San Diego region

UC San Diego Sulpizio Cardiovascular Center (SCVC) will officially open its doors to the public on Monday, August 8 after the California Department of Public Health (CDPH) certified the SCVC for patient care.

9 Aug 2011

Debate on rationality of coronary angiography in low risk patients continues

A new study reveals that American hospitals vary widely in how they decide who's eligible for an invasive type of heart scan.

9 Aug 2011

Soy useless for menopause

In their two year study they found that there were no differences in changes in bone density or menopausal symptoms between women taking soy and those taking a placebo, although women taking isoflavones did have more hot flashes, Dr. Silvina Levis of the University of Miami and colleagues reported in the August 8/22 issue of Archives of Internal Medicine.

8 Aug 2011

U.S. District Court rules in favor of POZEN in Treximet patent litigation

POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that the United States District Court for the Eastern District of Texas has issued a favorable verdict in the litigation between POZEN and several generic pharmaceutical companies which had filed Abbreviated New Drug Applications (ANDAs) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic copies of Treximet.

8 Aug 2011

Study finds connection between public health spending and population health

A groundbreaking new study published in the journal, Health Affairs, suggests that increases in public health spending result in healthier people, especially in communities with fewer resources.

6 Aug 2011

Osiris second quarter revenues increase to $10.4 million

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory and cardiovascular disease areas and wound healing, announced today its results for the second quarter ended June 30, 2011.

5 Aug 2011

Study sheds new light on how surgery impacts chronic kidney disease, bone health

Researchers at the University of California, San Diego School of Medicine have shed new light on how surgery impacts both chronic kidney disease and bone health, particularly in women.

5 Aug 2011

New research highlights urgent need to develop specific guidelines for HIV-infected children

Children with HIV have persistently high levels of cholesterol and other lipids during treatment with antiretroviral medications, according to a pair of studies in JAIDS: Journal of Acquired Immune Deficiency Syndromes.

4 Aug 2011

Study: Chronic mitral valve disease similar in humans and dogs

For more than 15 years, Kansas State University researcher Michele Borgarelli has studied heart diseases in man's best friend.

4 Aug 2011

Conference to focus on connection between fluid balance and hypertension

Each day we consume liquids in order to keep hydrated and maintain our body's fluid balance. But just as a water balloon can get overtaxed by too much liquid, the human body is negatively affected when it retains fluids because it is unable to eliminate them properly. One of the key variables influencing how much fluid we hold in our bodies is ordinary table salt.

3 Aug 2011

Childhood mistreatment may increase risk of coronary heart disease in middle age

For all the ills that result from bad parenting, new evidence from an epidemiological study of thousands of people suggests coronary heart disease (CHD) might be added to that list.

3 Aug 2011

A little exercise better than none for heart health

According to a new study getting even a little exercise is better than getting none at all, and this may hold especially true for women.

1 Aug 2011

FDA approves Medtronic's IDE for Advisa DR MRI SureScan pacing system

Medtronic, Inc. today announced U.S. Food and Drug Administration approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating Advisa DR MRI SureScan pacing system.

From Medtronic 1 Aug 2011

Stealth presents Bendavia at AHA's Cardiovascular Scientific Sessions

Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies for diseases with unmet medical needs, presented its lead clinical candidate, Bendavia, during the 2011 American Heart Association's (AHA) Cardiovascular Scientific Sessions.

1 Aug 2011

Intensive glycaemic control may negatively affect a person's quality of life

Research published in The Cochrane Library found that the risk of death and cardiovascular disease, such as stroke, was unchanged whether glucose control was intense or conventional.

1 Aug 2011